Seitarou Omoto Selected Research

Seitarou Omoto Research Topics

6	Type 2 Diabetes Mellitus (MODY) 04/2009 - 12/2004
3	Hyperlipidemias (Hyperlipidemia) 01/2012 - 01/2008
2	Thrombosis (Thrombus) 01/2012 - 09/2009
2	Hypertension (High Blood Pressure) 01/2006 - 01/2005
1	Atherosclerosis 02/2009
1	Hypoadiponectinemia 01/2006
1	Hyperglycemia 01/2006
1	Diabetes Complications 01/2006
1	Diabetic Angiopathies (Diabetic Angiopathy) 09/2005
1	Hypercholesterolemia 01/2005
1	Thrombophilia 12/2004

7	AdiponectinIBA 01/2012 - 09/2005
4	RV 538 (PDMP)IBA 01/2012 - 01/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 02/2009
3	pitavastatin (itavastatin)FDA Link 01/2012 - 01/2008
2	ChemokinesIBA 09/2009 - 01/2005
2	Eicosapentaenoic AcidIBA 04/2009 - 02/2009
2	Cell Adhesion MoleculesIBA 01/2008 - 12/2004
2	SelectinsIBA 01/2008 - 12/2004
2	E-SelectinIBA 01/2006 - 09/2005
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2006 - 09/2005
2	Annexin A5IBA 09/2005 - 01/2005
2	P-SelectinIBA 09/2005 - 12/2004
1	Plasminogen Activator Inhibitor 1IBA 01/2012
1	Angiopoietin-2IBA 04/2009
1	AngiopoietinsIBA 04/2009
1	oxidized low density lipoproteinIBA 01/2008
1	CholesterolIBA 01/2008
1	Peptides (Polypeptides)IBA 01/2006
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2006
1	Lipopolysaccharide ReceptorsIBA 01/2006
1	Antihypertensive Agents (Antihypertensives)IBA 01/2006
1	Valsartan (Vals)FDA Link 01/2006
1	sarpogrelateIBA 09/2005
1	Serotonin AntagonistsIBA 09/2005
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 09/2005
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2005
1	2- (4- methyl- 2,6- dinitroanilino)- N- methylpropionamide (MDMP)IBA 01/2005
1	CalciumIBA 01/2005
1	Chemokine CCL5IBA 01/2005
1	CC ChemokinesIBA 01/2005
1	Nifedipine (Adalat)FDA LinkGeneric 01/2005
1	Simvastatin (Zocor)FDA LinkGeneric 12/2004
1	Losartan (Cozaar)FDA LinkGeneric 12/2004
1	LipidsIBA 12/2004

3	Therapeutics 01/2006 - 12/2004